DN
Publications
82
Views
13,902
Downloads
5,781
Supervised works
2
Items per page
1 - 82 of 82
Title Published in Access level OA Policy Year Views Downloads
The Importance of MRI in the Early Diagnosis of Acute Invasive Fungal RhinosinusitisDiagnostics
accessLevelPublic
2025 91 10
Antifungal treatment duration in hematology patients with invasive mold infections : a real-life updateOpen forum infectious diseases
accessLevelPublic
2024 39 24
Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)Open forum infectious diseases
accessLevelPublic
2024 25 39
Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ?Open forum infectious diseases
accessLevelPublic
2024 70 24
Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant RecipientsTransplant international
accessLevelPublic
2024 74 29
BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort StudyAmerican journal of transplantation
accessLevelPublic
2024 11 11
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella speciesFrontiers in medicine
accessLevelPublic
2024 55 13
Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxisTransplant infectious disease
accessLevelPublic
2024 28 22
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter studyBone marrow transplantation
accessLevelPublic
2024 43 13
Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients : Recommendations from the EBMT practice harmonization and guidelines committeeCurrent research in translational medicine
accessLevelPublic
2024 17 4
Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplantOpen forum infectious diseases
accessLevelPublic
2023 38 33
Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities : A Multi-Center Retrospective StudyJournal of Fungi
accessLevelPublic
2023 63 40
Vaccine-preventable infections among solid organ transplant recipients in SwitzerlandJAMA network open
accessLevelPublic
2023 88 22
Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipientsClinical infectious diseases
accessLevelPublic
2023 73 37
Antifungal prophylaxis and pre-emptive therapy : when and how ?Molecular aspects of medicine
accessLevelPublic
2023 51 17
Duration of antifungal treatment in mold infection : when is enough ?Current opinion in infectious diseases
accessLevelPublic
2023 58 8
The present and future of blood virome in allogeneic hematopoietic cell transplant recipientsCurrent opinion in infectious diseases
accessLevelPublic
2023 65 15
Bloodstream infections in allogeneic haematopoietic cell recipients from the swiss transplant cohort study: trends of causative pathogens and resistance ratesBone marrow transplantation
accessLevelPublic
2023 111 45
American Society for Transplantation and Cellular Therapy Series, #6 : Management of Invasive Candidiasis in Hematopoietic Cell Transplantation RecipientsTransplantation and cellular therapy
accessLevelPublic
2023 47 27
CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant RecipientsOpen forum infectious diseases
accessLevelPublic
2023 81 21
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trialClinical infectious diseases
accessLevelPublic
2023 67 23
Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical TrialClinical infectious diseases
accessLevelPublic
2023 102 54
Invasive Aspergillosis and the Impact of Azole-resistanceCurrent fungal infection reports
accessLevelPublic
2023 45 22
Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients PlasmaViruses
accessLevelPublic
2023 117 66
Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological UpdateOpen forum infectious diseases
accessLevelPublic
2023 85 36
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant RecipientsAntimicrobial agents and chemotherapy
accessLevelPublic
2023 60 122
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell TransplantOpen forum infectious diseases
accessLevelPublic
2023 40 30
Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantésRevue médicale suisse
accessLevelPublic
2023 53 8
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?Open forum infectious diseases
accessLevelPublic
2022 242 132
Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort StudyThe Journal of infection
accessLevelPublic
2022 202 102
Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature reviewSwiss medical weekly
accessLevelPublic
2022 150 33
Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care HospitalsOpen forum infectious diseases
accessLevelPublic
2022 195 75
Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant RecipientsAntimicrobial agents and chemotherapy
accessLevelPublic
2022 60 80
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infectionsMycoses
accessLevelPublic
2022 247 113
Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomesAmerican journal of transplantation
accessLevelPublic
2022 153 80
Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/small bowel transplant recipientClinical transplantation
accessLevelRestricted
2022 213 0
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipientsAmerican journal of transplantation
accessLevelPublic
2022 179 61
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipientsAnnals of oncology
accessLevelPublic
2022 143 43
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?Mycoses
accessLevelPublic
2022 68 31
Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort StudyJournal of hospital infection
accessLevelPublic
2022 181 60
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipientsAmerican journal of transplantation
accessLevelPublic
2022 165 67
Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational StudyTropical medicine and infectious disease
accessLevelPublic
2021 199 99
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?Clinical microbiology and infection
accessLevelPublic
2021 182 78
Progress and current challenges in the management of invasive fungal infections in hematologic malignancy patients and allogeneic hematopoietic cell transplant recipients
accessLevelPublic
2021 275 383
Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort StudyVaccines
accessLevelPublic
2021 168 157
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort studyAmerican journal of transplantation
accessLevelPublic
2021 225 95
Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipientsImmunity, inflammation and disease
accessLevelPublic
2021 286 80
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018Antimicrobial resistance and infection control
accessLevelPublic
2021 313 74
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort studyAmerican journal of transplantation
accessLevelPublic
2021 116 81
Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experienceMycopathologia
accessLevelPublic
2021 202 109
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipientsMedical mycology
accessLevelRestricted
2021 279 1
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of responseBMC infectious diseases
accessLevelPublic
2021 120 110
Differences between infectious disease events in first liver transplant versus retransplantation in the Swiss Transplant Cohort StudyLiver transplantation
accessLevelRestricted
2021 110 0
Editorial: Transplant infectious disease landscape in the COVID19-EraCurrent opinion in infectious diseases
accessLevelRestricted
2021 155 0
The EHA research roadmap: infections in hematologyHemaSphere
accessLevelPublic
2021 164 73
Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with LetermovirAntimicrobial agents and chemotherapy
accessLevelPublic
2021 193 283
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS SurveyOpen forum infectious diseases
accessLevelPublic
2021 54 49
Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantationJournal of Fungi
accessLevelPublic
2021 151 98
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort studyThe journal of antimicrobial chemotherapy
accessLevelRestricted
2021 169 0
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsMedical mycology
accessLevelRestricted
2021 136 0
Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective studyClinical Infectious Diseases
accessLevelPublic
2020 196 478
Risk factors for candidemia: a prospective matched case-control studyCritical Care
accessLevelPublic
2020 302 100
Response to "Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study"Blood advances
accessLevelPublic
2020 164 38
Emerging echinocandin-resistant Candida albicans and glabrata in SwitzerlandInfection
accessLevelPublic
2020 202 95
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort StudyAmerican Journal of Transplantation
accessLevelPublic
2020 254 98
Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain LesionsClinical infectious diseases
accessLevelRestricted
2020 231 0
Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigmMedical Mycology
accessLevelPublic
2020 172 234
Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipientsOpen Forum Infectious Diseases
accessLevelPublic
2020 426 109
First case of Cryptococcus gattii multilobar pneumonia in Switzerland and associated challengesSwiss Medical Weekly
accessLevelPublic
2020 349 119
Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipientTransplantation
accessLevelRestricted
2020 311 1
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort studyTransplant Infectious Disease
accessLevelRestricted
2020 353 2
Prophylaxie antimicrobienne et approches thérapeutiques empiriques et préemptives pour la prévention des infections chez les receveurs de greffe allogénique de cellules hématopoïétiques
accessLevelPublic
2020 397 178
Infectiologie sur mesure - 1. Immunogénétique des maladies infectieuses : premiers pasRevue médicale suisse
accessLevelRestricted
2019 232 3
National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017Euro Surveillance
accessLevelPublic
2019 327 125
Antimicrobial prophylaxis and preemptive approaches for the prevention of infections in the stem cell transplant recipient, with analogies to the hematologic malignancy patientInfectious disease clinics of North America
accessLevelPublic
2019 136 146
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort StudyTransplant Infectious Disease
accessLevelRestricted
2018 484 0
Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapyHaematologica
accessLevelPublic
2018 220 126
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS)Clinical Microbiology and Infection
accessLevelPublic
2018 249 176
Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipientsTransplant Infectious Disease
accessLevelPublic
2018 260 93
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort studyTransplant Infectious Disease
accessLevelRestricted
2018 430 0
Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant CohortTransplant Infectious Disease
accessLevelRestricted
2018 353 1
First case of Candida auris in Switzerland: discussion about preventive strategiesSwiss Medical Weekly
accessLevelPublic
2018 462 197
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack